InsiderTrades

Form 4 for JNJ Johnson & Johnson

Accepted 2026-08-14 16:35:15 ET · period of report 2026-08-13 · accession 0000200406-26-000173 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2026-08-14 16:35 2026-08-13 JNJ Duato Joaquin CEO, COB, Dir M - OptEx $115.67 +123.3K 399.3K +45% +$14.26M
DM 2026-08-14 16:35 2026-08-13 JNJ Duato Joaquin CEO, COB, Dir S - Sale+OE $261.17 -123.3K 276.0K -31% -$32.20M
D 2026-08-14 16:35 2026-08-13 JNJ Duato Joaquin CEO, COB, Dir M - OptEx $0.00 -123.3K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-08-13 M A 123,291 $115.67 399,258 D — —
2 Common Common Stock 2026-08-13 S D 20,976 $262.00 378,282 D — —
3 Common Common Stock 2026-08-13 S D 102,315 $261.00 275,967 D — —
4 Derivative Employee Stock Options (Right to Buy) 2026-08-13 M D 123,291 $0.00 0 D $115.67 · 2020-02-14 to 2027-02-13 123,291 Common Stock (F2) Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests and is exercisable on the third anniversary of the grant date.